Drug Type Bacteriophage therapy |
Synonyms CRISPR/Cas3-engineered bacteriophage (Locus Biosciences) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Tract Infections | Preclinical | US | - | |
Klebsiella Infections | Discovery | US | - |